PharmaFluidics SA
13.8 FTEThe score of PharmaFluidics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +755 % Total assets +211 % Headcount (avg FTE) -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaFluidics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €1.44m | ||||
| Net result | −€1.58m | ||||
| Equity | €15.9m | ||||
| Cash | 69,334 € | ||||
| EBITDA | −€1.18m | ||||
| Total assets | €16.4m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
PharmaFluidics's financial analysis
- Solvency97.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaFluidics
PharmaFluidics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.350.565
- VAT number
- BE0832350565
- Peppol
- Registered · 0208:0832350565 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Dec 2010
- Registered office
- 9052 Ghent
- Size
- Small · 13.8 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
PharmaFluidics (SA) has been based in Ghent since 2010, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports revenue of €1.44m, a net loss of €1.58m and equity of €15.9m. With 13.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 97.1%, above the median of its sector (60.4%).
Companies similar to PharmaFluidics
Companies in the same business, of comparable size and area, outside its group.
- X-RIS Manufacture of instruments and appliances for measuring, testing and navigation Seraing · balance sheet €10.8m
- Biocartis Research and experimental development on natural sciences and engineering Mechelen · balance sheet €61.8m
- Diagenode Research and experimental development on natural sciences and engineering Seraing · balance sheet €21.1m
- Istar Medical Manufacture of medical and dental instruments and supplies Wavre · balance sheet €15.6m
- Unisensor Manufacture of basic pharmaceutical products Seraing · balance sheet €19.2m
- CellCarta Research and experimental development on natural sciences and engineering Antwerp · balance sheet €60.5m
- Wielandts Ultra Precision Machining Technologies Engineering activities and related technical consultancy Seraing · balance sheet €8.49m
- Univercells Technologies Manufacture of other chemical products n.e.c. Nivelles · balance sheet €16.2m
Frequently asked questions about PharmaFluidics
What is the revenue of PharmaFluidics?
According to the 2025 annual accounts filed with the NBB, the revenue of PharmaFluidics amounts to 1,438,123 €.
What is the VAT number of PharmaFluidics?
In Belgium, the VAT number is the company number prefixed with BE: BE0832350565 for PharmaFluidics, if the company is VAT-registered. Its company number (CBE) is 0832.350.565.
Where is the registered office of PharmaFluidics?
According to the CBE register, the registered office of PharmaFluidics is in 9052 Ghent.
What is the equity of PharmaFluidics?
At the close of the 2025 financial year, the equity of PharmaFluidics amounts to 15,878,117 €, a solvency of 97.1% of total assets.
How many people work at PharmaFluidics?
13.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages PharmaFluidics?
The register lists 3 active mandates at PharmaFluidics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaFluidics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →